Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders.
Amel DjoudiRodolfo Molina-PeñaNatalia Helen FerreiraIlaria OttonelliGiovanni TosiEmmanuel GarcionFrank BouryPublished in: International journal of molecular sciences (2022)
Hyaluronic acid (HA) is a Glycosaminoglycan made of disaccharide units containing N-acetyl-D-glucosamine and glucuronic acid. Its molecular mass can reach 10 MDa and its physiological properties depend on its polymeric property, polyelectrolyte feature and viscous nature. HA is a ubiquitous compound found in almost all biological tissues and fluids. So far, HA grades are produced by biotechnology processes, while in the human organism it is a major component of the extracellular matrix (ECM) in brain tissue, synovial fluid, vitreous humor, cartilage and skin. Indeed, HA is capable of forming hydrogels, polymer crosslinked networks that are very hygroscopic. Based on these considerations, we propose an overview of HA-based scaffolds developed for brain cancer treatment, central and peripheral nervous systems, discuss their relevance and identify the most successful developed systems.
Keyphrases
- hyaluronic acid
- extracellular matrix
- resting state
- white matter
- endothelial cells
- tissue engineering
- gene expression
- machine learning
- cerebral ischemia
- deep learning
- single molecule
- multiple sclerosis
- bone marrow
- blood brain barrier
- breast cancer cells
- soft tissue
- subarachnoid hemorrhage
- cell proliferation
- cell therapy
- functional connectivity
- induced pluripotent stem cells
- mesenchymal stem cells